Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review.
Zhanna OganesovaJohn PembertonAdrian Carl BrownPublished in: Diabetic medicine : a journal of the British Diabetic Association (2024)
In the face of these research gaps, we urge for the commercial claims suggesting the utility of the device in PNLD to be labelled as misleading. We argue that there is a regulatory inadequacy that fuels 'off-label' CGM distribution and calls for the strengthening of post-market clinical follow-up oversight for CGMs. We hope this will help to avert the continued misinformation risk to PNLD and 'off-label' exacerbation of health disparities.
Keyphrases
- health insurance
- type diabetes
- social media
- chronic obstructive pulmonary disease
- public health
- healthcare
- affordable care act
- cardiovascular disease
- mental health
- glycemic control
- health information
- transcription factor
- blood glucose
- health promotion
- risk assessment
- blood pressure
- weight loss
- human health
- climate change